B2M | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

603 results for “B2M”

Blood Protein Biomarkers B2M and Cystatin C Predict Future Disability in Very Old Adults

Applied StemCell Launches Hypoimmunogenic hiPSC Products to Advance Allogeneic Cell Therapy Development

Caribou Biosciences to Present First Clinical Data from Dual Allogeneic CAR-T Programs in Lymphoma and Multiple Myeloma

CARsgen's THANK-u Plus Platform Drives Advancements in Allogeneic CAR-T Therapy for Hematologic Malignancies

Pembrolizumab-Vorinostat Combination Shows Promise in Recurrent Squamous Cell Carcinoma

$22 Million Boost for Australian Cancer Clinical Trials to Enhance Research and Access

Faron Pharmaceuticals Secures €12M to Advance Promising MDS Treatment Bexmarilimab

Pathos AI Secures $62M Series C Funding to Advance AI-Powered Drug Development

Evidium Secures $22M Series A to Advance Transparent Healthcare AI Platform

Kivu Biosciences Secures $92M to Advance 'Kinder, Gentler' Antibody-Drug Conjugates

Page 1 of 8